BindingDB logo
myBDB logout

null

SMILES: CN(C)CCOc1cccc(Cn2cc(cn2)-c2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c1

InChI Key: InChIKey=ZQODOCMKSVFZBR-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 209072   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Bcl-2-like protein 1


(Homo sapiens (Human))
BDBM209072
PNG
(US9266877, 18)
Show SMILES CN(C)CCOc1cccc(Cn2cc(cn2)-c2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c1
Show InChI InChI=1S/C37H35N7O4S/c1-42(2)17-18-48-27-9-5-7-24(19-27)21-44-22-26(20-38-44)28-13-14-33(40-34(28)36(46)47)43-16-15-25-8-6-10-29(30(25)23-43)35(45)41-37-39-31-11-3-4-12-32(31)49-37/h3-14,19-20,22H,15-18,21,23H2,1-2H3,(H,46,47)(H,39,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
38 -10.1n/an/an/an/an/an/a25



ABBVIE INC.

US Patent


Assay Description
The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluoresc...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair
Bcl-2-like protein 1


(Mus musculus (Mouse))
BDBM209072
PNG
(US9266877, 18)
Show SMILES CN(C)CCOc1cccc(Cn2cc(cn2)-c2ccc(nc2C(O)=O)N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)c1
Show InChI InChI=1S/C37H35N7O4S/c1-42(2)17-18-48-27-9-5-7-24(19-27)21-44-22-26(20-38-44)28-13-14-33(40-34(28)36(46)47)43-16-15-25-8-6-10-29(30(25)23-43)35(45)41-37-39-31-11-3-4-12-32(31)49-37/h3-14,19-20,22H,15-18,21,23H2,1-2H3,(H,46,47)(H,39,41,45)
PDB

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 621n/an/an/an/a



ABBVIE INC.

US Patent


Assay Description
The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair